Published in Immunity on September 24, 2010
HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med (2011) 5.99
Metabolic regulation of T lymphocytes. Annu Rev Immunol (2013) 3.67
Regulation of immune responses by mTOR. Annu Rev Immunol (2011) 3.08
The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and function. Nat Immunol (2011) 3.03
Regulation and function of mTOR signalling in T cell fate decisions. Nat Rev Immunol (2012) 2.79
PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells. J Exp Med (2012) 2.58
CD8(+) T cells: foot soldiers of the immune system. Immunity (2011) 2.45
Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat Immunol (2013) 2.37
Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function. Diabetes (2012) 2.02
mTOR, metabolism, and the regulation of T-cell differentiation and function. Immunol Rev (2012) 1.74
Molecular regulation of effector and memory T cell differentiation. Nat Immunol (2014) 1.70
T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells. Immunol Rev (2011) 1.69
Pathogen-induced inflammatory environment controls effector and memory CD8+ T cell differentiation. J Immunol (2011) 1.66
The liver kinase B1 is a central regulator of T cell development, activation, and metabolism. J Immunol (2011) 1.62
PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances. Biochem J (2012) 1.56
Therapeutic opportunities for manipulating T(Reg) cells in autoimmunity and cancer. Nat Rev Drug Discov (2013) 1.50
Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase. Nat Chem Biol (2012) 1.46
TOR in the immune system. Curr Opin Cell Biol (2011) 1.44
Emerging role of autophagy in kidney function, diseases and aging. Autophagy (2012) 1.43
The transcription factor FoxO1 sustains expression of the inhibitory receptor PD-1 and survival of antiviral CD8(+) T cells during chronic infection. Immunity (2014) 1.40
T-cell tolerance: central and peripheral. Cold Spring Harb Perspect Biol (2012) 1.28
Metabolic control of the Treg/Th17 axis. Immunol Rev (2013) 1.26
Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics. Cancer Res (2014) 1.26
Central role for interleukin-2 in type 1 diabetes. Diabetes (2012) 1.19
Orchestrating B cell lymphopoiesis through interplay of IL-7 receptor and pre-B cell receptor signalling. Nat Rev Immunol (2013) 1.18
Rapamycin unbalances the polarization of human macrophages to M1. Immunology (2013) 1.17
mTOR, linking metabolism and immunity. Semin Immunol (2013) 1.17
TSC1 regulates the balance between effector and regulatory T cells. J Clin Invest (2013) 1.13
The role of tuberous sclerosis complex 1 in regulating innate immunity. J Immunol (2012) 1.13
Role of PI3K/Akt signaling in memory CD8 T cell differentiation. Front Immunol (2013) 1.13
TSC1/2 signaling complex is essential for peripheral naïve CD8+ T cell survival and homeostasis in mice. PLoS One (2012) 1.12
mTOR and metabolic pathways in T cell quiescence and functional activation. Semin Immunol (2013) 1.11
mTOR and lymphocyte metabolism. Curr Opin Immunol (2013) 1.11
L-asparaginase II produced by Salmonella typhimurium inhibits T cell responses and mediates virulence. Cell Host Microbe (2012) 1.06
Metabolic regulation in progression to autoimmune diabetes. PLoS Comput Biol (2011) 1.06
Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus. J Immunol (2014) 1.03
Analysis of sirtuin 1 expression reveals a molecular explanation of IL-2-mediated reversal of T-cell tolerance. Proc Natl Acad Sci U S A (2012) 1.02
Homeostasis and the importance for a balance between AKT/mTOR activity and intracellular signaling. Curr Med Chem (2012) 1.02
Regulation of T cells by mTOR: the known knowns and the known unknowns. Trends Immunol (2014) 1.02
Regulation of mast cell survival and function by tuberous sclerosis complex 1. Blood (2012) 1.01
Qualitatively different T cell phenotypic responses to IL-2 versus IL-15 are unified by identical dependences on receptor signal strength and duration. J Immunol (2013) 1.01
The Critical Role of IL-15-PI3K-mTOR Pathway in Natural Killer Cell Effector Functions. Front Immunol (2014) 0.99
T lymphocytes from patients with systemic lupus erythematosus are resistant to induction of autophagy. FASEB J (2012) 0.99
Transcriptional regulation of gene expression during osmotic stress responses by the mammalian target of rapamycin. Nucleic Acids Res (2012) 0.98
Progesterone suppresses the mTOR pathway and promotes generation of induced regulatory T cells with increased stability. Eur J Immunol (2012) 0.98
A simple theoretical framework for understanding heterogeneous differentiation of CD4+ T cells. BMC Syst Biol (2012) 0.97
MyD88 is essential to sustain mTOR activation necessary to promote T helper 17 cell proliferation by linking IL-1 and IL-23 signaling. Proc Natl Acad Sci U S A (2013) 0.97
Molecular mechanisms of metabolic reprogramming in proliferating cells: implications for T-cell-mediated immunity. Immunology (2012) 0.97
Synchronizing transcriptional control of T cell metabolism and function. Nat Rev Immunol (2015) 0.97
Intersection of mTOR and STAT signaling in immunity. Trends Immunol (2014) 0.97
Protein kinase C-θ inhibits inducible regulatory T cell differentiation via an AKT-Foxo1/3a-dependent pathway. J Immunol (2012) 0.96
Modulation of T Cell Metabolism and Function through Calcium Signaling. Front Immunol (2013) 0.93
IL-15-PI3K-AKT-mTOR: A Critical Pathway in the Life Journey of Natural Killer Cells. Front Immunol (2015) 0.93
Serine-threonine kinases in TCR signaling. Nat Immunol (2014) 0.92
Drosophila as a model for the two myeloid blood cell systems in vertebrates. Exp Hematol (2014) 0.92
Identification of Ser/Thr phosphorylation sites in the C2-domain of phospholipase C γ2 (PLCγ2) using TRPM7-kinase. Cell Signal (2012) 0.92
Dietary intervention in acne: Attenuation of increased mTORC1 signaling promoted by Western diet. Dermatoendocrinol (2012) 0.92
Tuberous sclerosis 1 promotes invariant NKT cell anergy and inhibits invariant NKT cell-mediated antitumor immunity. J Immunol (2014) 0.91
T cell immunity and cardiovascular metabolic disorders: does metabolism fuel inflammation? Front Immunol (2012) 0.90
Insight into the role of mTOR and metabolism in T cells reveals new potential approaches to preventing graft rejection. Curr Opin Organ Transplant (2014) 0.89
microRNA-mediated regulation of mTOR complex components facilitates discrimination between activation and anergy in CD4 T cells. J Exp Med (2014) 0.89
Low dose rapamycin exacerbates autoimmune experimental uveitis. PLoS One (2012) 0.89
Murine dendritic cell rapamycin-resistant and rictor-independent mTOR controls IL-10, B7-H1, and regulatory T-cell induction. Blood (2013) 0.89
Environmental and metabolic sensors that control T cell biology. Front Immunol (2015) 0.89
STAT heterodimers in immunity: A mixed message or a unique signal? JAKSTAT (2013) 0.89
Polyunsaturated Fatty Acid-derived lipid mediators and T cell function. Front Immunol (2014) 0.88
Differential regulation of primary and memory CD8 T cell immune responses by diacylglycerol kinases. J Immunol (2012) 0.88
Mutual antagonism of TGF-beta and Interleukin-2 in cell survival and lineage commitment of induced regulatory T cells. Cell Death Differ (2012) 0.88
Matched and mismatched metabolic fuels in lymphocyte function. Semin Immunol (2013) 0.88
T cell receptor-dependent activation of mTOR signaling in T cells is mediated by Carma1 and MALT1, but not Bcl10. Sci Signal (2014) 0.88
Rapamycin attenuates airway hyperreactivity, goblet cells, and IgE in experimental allergic asthma. J Immunol (2011) 0.87
Role of adipokines signaling in the modulation of T cells function. Front Immunol (2013) 0.87
Metabolic crosstalk between host and pathogen: sensing, adapting and competing. Nat Rev Microbiol (2016) 0.87
Peri-alloHCT IL-33 administration expands recipient T-regulatory cells that protect mice against acute GVHD. Blood (2016) 0.87
Feeding an army: The metabolism of T cells in activation, anergy, and exhaustion. Mol Immunol (2015) 0.87
Metabolic regulation of regulatory T cell development and function. Front Immunol (2014) 0.86
Highlights of the advances in basic immunology in 2011. Cell Mol Immunol (2012) 0.86
Vitamin D: a new player in the world of mTOR signaling. Cell Cycle (2011) 0.86
Metabolic regulation of T cell differentiation and function. Mol Immunol (2015) 0.85
Sirolimus ameliorates inflammatory responses by switching the regulatory T/T helper type 17 profile in murine colitis. Immunology (2013) 0.85
Metabolic syndrome and the immunological affair with the blood-brain barrier. Front Immunol (2015) 0.85
Immune memory-boosting dose of rapamycin impairs macrophage vesicle acidification and curtails glycolysis in effector CD8 cells, impairing defense against acute infections. J Immunol (2014) 0.85
Differential effects of rapamycin and dexamethasone in mouse models of established allergic asthma. PLoS One (2013) 0.84
Inducing and Administering Tregs to Treat Human Disease. Front Immunol (2016) 0.84
Cyclosporin A inhibits colon cancer cell growth independently of the calcineurin pathway. Cell Cycle (2012) 0.84
Harnessing memory adaptive regulatory T cells to control autoimmunity in type 1 diabetes. J Mol Cell Biol (2011) 0.84
The potential mechanistic link between allergy and obesity development and infant formula feeding. Allergy Asthma Clin Immunol (2014) 0.84
Expression of CD39 on Activated T Cells Impairs their Survival in Older Individuals. Cell Rep (2016) 0.84
Activation of TGF-β-induced non-Smad signaling pathways during Th17 differentiation. Immunol Cell Biol (2015) 0.84
Streptavidin suppresses T cell activation and inhibits IL-2 production and CD25 expression. Cytokine (2012) 0.83
Mechanisms that regulate peripheral immune responses to control organ-specific autoimmunity. Clin Dev Immunol (2011) 0.83
Apoptosis and autophagy in the regulation of T lymphocyte function. Immunol Res (2011) 0.83
p27(Kip1) negatively regulates the magnitude and persistence of CD4 T cell memory. J Immunol (2012) 0.83
mTORC2 Deficiency in Myeloid Dendritic Cells Enhances Their Allogeneic Th1 and Th17 Stimulatory Ability after TLR4 Ligation In Vitro and In Vivo. J Immunol (2015) 0.82
Differential mTOR and ERK pathway utilization by effector CD4 T cells suggests combinatorial drug therapy of arthritis. Clin Immunol (2011) 0.82
The role of mechanistic target of rapamycin (mTOR) complexes signaling in the immune responses. Nutrients (2013) 0.82
Effect of post-exercise protein-leucine feeding on neutrophil function, immunomodulatory plasma metabolites and cortisol during a 6-day block of intense cycling. Eur J Appl Physiol (2013) 0.82
The role of nuclear receptors in regulation of Th17/Treg biology and its implications for diseases. Cell Mol Immunol (2015) 0.82
The second-generation mTOR kinase inhibitor INK128 exhibits anti-inflammatory activity in lipopolysaccharide-activated RAW 264.7 cells. Inflammation (2014) 0.82
Harnessing autophagy for adoptive T-cell therapy. Immunotherapy (2012) 0.81
Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (2009) 49.82
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med (2003) 26.05
Defining the role of mTOR in cancer. Cancer Cell (2007) 21.63
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell (2006) 18.36
The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science (2008) 14.08
Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity (2007) 12.98
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature (2004) 12.72
Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol (1989) 12.08
mTOR and cancer: insights into a complex relationship. Nat Rev Cancer (2006) 11.86
TOR, a central controller of cell growth. Cell (2000) 10.41
IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol (2004) 10.08
mTOR regulates memory CD8 T-cell differentiation. Nature (2009) 10.07
mTOR signaling at a glance. J Cell Sci (2009) 8.66
Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat Immunol (2005) 8.27
Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature (2009) 8.09
TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell (2006) 7.49
T cell anergy. Annu Rev Immunol (2001) 7.15
The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity (2009) 6.86
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med (2009) 6.80
The CD28 signaling pathway regulates glucose metabolism. Immunity (2002) 6.65
Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood (2005) 6.49
The two TORCs and Akt. Dev Cell (2007) 6.17
The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J Exp Med (2008) 6.07
T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci U S A (2008) 5.97
Fuel feeds function: energy metabolism and the T-cell response. Nat Rev Immunol (2005) 5.29
Rheb promotes cell growth as a component of the insulin/TOR signalling network. Nat Cell Biol (2003) 5.01
Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling. EMBO J (2008) 4.79
Th17: the third member of the effector T cell trilogy. Curr Opin Immunol (2007) 4.78
Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. Nat Immunol (2008) 4.69
Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N Engl J Med (2009) 4.59
Kruppel-like factor 2 regulates thymocyte and T-cell migration. Nature (2006) 4.51
Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. Nat Immunol (2009) 4.31
Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J Immunol (2006) 4.23
The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. Immunity (2010) 4.21
Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. Immunity (2010) 4.06
Rheb fills a GAP between TSC and TOR. Trends Biochem Sci (2003) 3.90
Cutting Edge: IL-12 inversely regulates T-bet and eomesodermin expression during pathogen-induced CD8+ T cell differentiation. J Immunol (2006) 3.73
Revving the engine: signal transduction fuels T cell activation. Immunity (2007) 3.57
An emerging role of mTOR in lipid biosynthesis. Curr Biol (2009) 3.50
Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycinassociated protein. Proc Natl Acad Sci U S A (1999) 3.49
IL-7 enhances the survival and maintains the size of naive T cells. J Immunol (2001) 3.39
Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells. Blood (2007) 3.27
Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat Immunol (2010) 3.05
Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability. Biochem J (2003) 2.84
The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR. Nat Immunol (2009) 2.73
Regulation of T lymphocyte metabolism. J Immunol (2004) 2.55
Developmental plasticity of Th17 and Treg cells. Curr Opin Immunol (2009) 2.53
A role for mammalian target of rapamycin in regulating T cell activation versus anergy. J Immunol (2007) 2.53
Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes (2008) 2.52
Target of rapamycin (TOR): balancing the opposing forces of protein synthesis and degradation. Curr Opin Genet Dev (1999) 2.48
Inflammatory cytokines as a third signal for T cell activation. Curr Opin Immunol (2010) 2.44
Transcription factor LKLF is sufficient to program T cell quiescence via a c-Myc-dependent pathway. Nat Immunol (2001) 2.36
Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation. Proc Natl Acad Sci U S A (2002) 2.35
A new analysis of allogeneic interactions. Aust J Exp Biol Med Sci (1975) 2.33
Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors. Proc Natl Acad Sci U S A (2002) 2.32
Glutamine uptake and metabolism are coordinately regulated by ERK/MAPK during T lymphocyte activation. J Immunol (2010) 2.31
Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation. J Immunol (1999) 2.26
rheb, a growth factor- and synaptic activity-regulated gene, encodes a novel Ras-related protein. J Biol Chem (1994) 2.25
Infectious tolerance via the consumption of essential amino acids and mTOR signaling. Proc Natl Acad Sci U S A (2009) 2.22
Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells. J Exp Med (2010) 2.17
Mechanisms of costimulation. Immunol Rev (2009) 2.13
Anergic T cells are metabolically anergic. J Immunol (2009) 2.12
Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells. Int Immunopharmacol (2007) 2.08
FOXO1 regulates L-Selectin and a network of human T cell homing molecules downstream of phosphatidylinositol 3-kinase. J Immunol (2008) 1.97
Metabolism in T cell activation and differentiation. Curr Opin Immunol (2010) 1.97
The multiple facets of mTOR in immunity. Trends Immunol (2009) 1.89
Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells. Eur J Immunol (2008) 1.89
CD28 costimulation is essential for human T regulatory expansion and function. J Immunol (2008) 1.86
Prolonged TCR/CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycin. J Immunol (2006) 1.81
Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade. J Clin Invest (2009) 1.80
Colicins: structures, modes of action, transfer through membranes, and evolution. Arch Microbiol (1994) 1.77
Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy. Lancet (2002) 1.76
The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A. Immunity (2000) 1.74
Cutting edge: Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin. J Immunol (2008) 1.71
Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin. PLoS One (2009) 1.69
The multifunctional role of mTOR in innate immunity: implications for transplant immunity. Am J Transplant (2009) 1.60
Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors. Cancer Res (2009) 1.58
Regulators of the Toll and Imd pathways in the Drosophila innate immune response. Trends Immunol (2005) 1.56
De novo induction of antigen-specific CD4+CD25+Foxp3+ regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR. J Leukoc Biol (2008) 1.52
5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis. J Immunol (2005) 1.49
PI3 kinase signalling blocks Foxp3 expression by sequestering Foxo factors. J Exp Med (2010) 1.47
The role of cell division in the induction of clonal anergy. Immunol Today (1992) 1.46
The role of mTOR in memory CD8 T-cell differentiation. Immunol Rev (2010) 1.41
An Slfn2 mutation causes lymphoid and myeloid immunodeficiency due to loss of immune cell quiescence. Nat Immunol (2010) 1.39
mTOR: taking cues from the immune microenvironment. Immunology (2009) 1.38
Rheb interacts with Raf-1 kinase and may function to integrate growth factor- and protein kinase A-dependent signals. Mol Cell Biol (1997) 1.33
Amino acids and mTOR signalling in anabolic function. Biochem Soc Trans (2007) 1.31
Is cancer dangerous to the immune system? Semin Immunol (1996) 1.31
Phosphoinositide 3-kinase and the mammalian target of rapamycin pathways control T cell migration. Ann N Y Acad Sci (2010) 1.28
Interferon-gamma engages the p70 S6 kinase to regulate phosphorylation of the 40S S6 ribosomal protein. Exp Cell Res (2004) 1.25
Dissecting the mechanism of T-cell anergy with immunophilin ligands. Curr Opin Investig Drugs (2006) 1.15
Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism. J Immunol (2005) 1.12
The novel cyclophilin binding compound, sanglifehrin A, disassociates G1 cell cycle arrest from tolerance induction. J Immunol (2004) 1.08
Sequence motifs in IL-4R alpha mediating cell-cycle progression of primary lymphocytes. J Immunol (2005) 1.08
Ex vivo rapamycin generates Th1/Tc1 or Th2/Tc2 Effector T cells with enhanced in vivo function and differential sensitivity to post-transplant rapamycin therapy. Biol Blood Marrow Transplant (2006) 1.06
Negative regulators in homeostasis of naïve peripheral T cells. Immunol Res (2008) 1.05
Antagonistic roles for CTLA-4 and the mammalian target of rapamycin in the regulation of clonal anergy: enhanced cell cycle progression promotes recall antigen responsiveness. J Immunol (2001) 1.04
Inhibition of amino acid-mTOR signaling by a leucine derivative induces G1 arrest in Jurkat cells. Biochem Biophys Res Commun (2003) 1.02
How does the immune system distinguish self from nonself? Semin Immunol (2000) 1.01
Clonal anergy is maintained independently of T cell proliferation. J Immunol (2002) 1.00
Anergic T cells are metabolically anergic. J Immunol (2009) 2.12
The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation. Immunity (2010) 1.64
The composition and signaling of the IL-35 receptor are unconventional. Nat Immunol (2012) 1.63
mTORC1 and mTORC2 selectively regulate CD8⁺ T cell differentiation. J Clin Invest (2015) 1.18
Cutting edge: regulatory T cells do not mediate suppression via programmed cell death pathways. J Immunol (2011) 0.93
The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction. Immunity (2016) 0.77